{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:10:07Z","timestamp":1787839807467,"version":"build-2784847793"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,4]]},"DOI":"10.7759\/cureus.66118","type":"journal-article","created":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T11:59:12Z","timestamp":1722772752000},"source":"Crossref","is-referenced-by-count":2,"title":["Recurrent Fanconi Syndrome Induced by Lenalidomide: A Case Report"],"prefix":"10.7759","author":[{"given":"Irida","family":"Sharra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Lhoir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marin","family":"Des Grottes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Vaes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Guerisse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hct258","article-title":"Drug-induced renal Fanconi syndrome","volume":"107","author":"Hall AM","year":"2014","unstructured":"Hall AM, Bass P, Unwin RJ. Drug-induced renal Fanconi syndrome. QJM. 2014, 107:261-9. 10.1093\/qjmed\/hct258","journal-title":"QJM"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2003.50037","article-title":"Drug-induced Fanconi's syndrome","volume":"41","author":"Izzedine H","year":"2003","unstructured":"Izzedine H, Launay-Vacher V, Isnard-Bagnis C, Deray G. Drug-induced Fanconi's syndrome. Am J Kidney Dis. 2003, 41:292-309. 10.1053\/ajkd.2003.50037","journal-title":"Am J Kidney Dis"},{"key":"ref3","unstructured":"Fanconi syndrome. (2011). Accessed. September 23, 2023: https:\/\/www.uspharmacist.com\/article\/fanconi-syndrome."},{"key":"ref4","unstructured":"Tout savoir du syndrome de Fanconi (2012). Accessed Juin 17. (2019). https.\/\/nephro.blog\/2012\/03\/06\/tout-savoir-du-syndrome-de-fanconi\/."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/ndtplus\/sfn044","article-title":"Reversible Fanconi syndrome due to lenalidomide","volume":"1","author":"Glezerman IG","year":"2008","unstructured":"Glezerman IG, Kewalramani T, Jhaveri K. Reversible Fanconi syndrome due to lenalidomide. NDT Plus. 2008, 1:215-7. 10.1093\/ndtplus\/sfn044","journal-title":"NDT Plus"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2010-0070","article-title":"Lenalidomide-induced acute interstitial nephritis","volume":"15","author":"Lipson EJ","year":"2010","unstructured":"Lipson EJ, Huff CA, Holanda DG, McDevitt MA, Fine DM. Lenalidomide-induced acute interstitial nephritis. Oncologist. 2010, 15:961-4. 10.1634\/theoncologist.2010-0070","journal-title":"Oncologist"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.71.834.211","article-title":"Fractional excretion of potassium in normal subjects and in patients with hypokalaemia","volume":"71","author":"Elisaf M","year":"1995","unstructured":"Elisaf M, Siamopoulos KC. Fractional excretion of potassium in normal subjects and in patients with hypokalaemia. Postgrad Med J. 1995, 71:211-2. 10.1136\/pgmj.71.834.211","journal-title":"Postgrad Med J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1586\/ehm.12.62","article-title":"Immunomodulatory drugs in multiple myeloma","volume":"6","author":"Andhavarapu S","year":"2013","unstructured":"Andhavarapu S, Roy V. Immunomodulatory drugs in multiple myeloma. Expert Rev Hematol. 2013, 6:69-82. 10.1586\/ehm.12.62","journal-title":"Expert Rev Hematol"},{"key":"ref9","unstructured":"Revlimid. (2008). Accessed. April 30, 2024: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/revlimid."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-2-36","article-title":"Mechanism of action of lenalidomide in hematological malignancies","volume":"2","author":"Kotla V","year":"2009","unstructured":"Kotla V, Goel S, Nischal S, Heuck C, Vivek K, Das B, Verma A. Mechanism of action of lenalidomide in hematological malignancies. J Hematol Oncol. 2009, 2:36. 10.1186\/1756-8722-2-36","journal-title":"J Hematol Oncol"},{"key":"ref11","unstructured":"Lenalidomide. (2018). Accessed. November 1, 2019: https:\/\/www.myelom.net\/downloads\/files\/lenalidomid-fr.pdf."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2009.00716.x","article-title":"Tenofovir-associated renal and bone toxicity","volume":"10","author":"Woodward CL","year":"2009","unstructured":"Woodward CL, Hall AM, Williams IG, et al.. Tenofovir-associated renal and bone toxicity. HIV Med. 2009, 10:482-7. 10.1111\/j.1468-1293.2009.00716.x","journal-title":"HIV Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2009.07.012","article-title":"Subclinical tubular injury in HIV-infected individuals on antiretroviral therapy: a cross-sectional analysis","volume":"54","author":"Hall AM","year":"2009","unstructured":"Hall AM, Edwards SG, Lapsley M, et al.. Subclinical tubular injury in HIV-infected individuals on antiretroviral therapy: a cross-sectional analysis. Am J Kidney Dis. 2009, 54:1034-42. 10.1053\/j.ajkd.2009.07.012","journal-title":"Am J Kidney Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/000456329803500116","article-title":"Sensitive assays for urinary retinol-binding protein and beta-2-glycoprotein-1 based on commercially available standards","volume":"35","author":"Lapsley M","year":"1998","unstructured":"Lapsley M, Akers K, Norden AG. Sensitive assays for urinary retinol-binding protein and beta-2-glycoprotein-1 based on commercially available standards. Ann Clin Biochem. 1998, 35:115-9. 10.1177\/000456329803500116","journal-title":"Ann Clin Biochem"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)92719-0","article-title":"Ifosfamide-induced FanconI syndrome","volume":"1","author":"Newbury-Ecob RA","year":"1989","unstructured":"Newbury-Ecob RA, Noble VW, Barbor PR. Ifosfamide-induced FanconI syndrome. Lancet. 1989, 1:1328. 10.1016\/S0140-6736(89)92719-0","journal-title":"Lancet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/255719-recurrent-fanconi-syndrome-induced-by-lenalidomide-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T11:59:18Z","timestamp":1722772758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/255719-recurrent-fanconi-syndrome-induced-by-lenalidomide-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,4]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.66118","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,4]]}}}